Leopoldina Home Menü

Leopoldina Home


Antiviral Drugs: Increasing Preparedness for the Next Pandemic (2022)

This statement was prepared by the National Academies of Sciences of the G7 states under the leadership of the German National Academy of Sciences Leopoldina to provide scientific advice to the G7 Summit of Heads of State and Government in Germany 2022.

(2022, 4 pages)

The widespread availability of antiviral drugs that can be used in addition to prophylactic vaccines in the event of a pandemic is a key component of effective pandemic preparedness. Experience with the COVID-19 pandemic has shown the world’s lack of preparedness for emerging pathogens with pandemic potential. Urgent action is therefore needed to develop new antiviral drugs. The G7 Academies call for fostering the discovery and development of specific and broad-spectrum antiviral drugs by providing long-term funding, building adequate infrastructures for efficient clinical studies, and promoting the international coordination in the field of pandemic preparedness.


Dr. Marina Koch-Krumrei

Leiterin der Abteilung Internationale Beziehungen

Phone 0345 - 47 239 - 830
Fax 0345 - 47 239 - 839
E-Mail marina.koch-krumrei (at)leopoldina.org